


Product Description
Dapagliflozin 5 mg & Vildagliptin 50 mg Tablet IP is used to treat Type 2 Diabetes Mellitus, a chronic condition that affects the way the body regulates blood sugar (glucose). This condition primarily results from insulin resistance or insufficient insulin production.
This tablet contains two active ingredients:
-
Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, helps lower blood sugar by promoting the removal of excess glucose through urine.
-
Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances glucose-dependent insulin secretion and reduces glucagon secretion, thereby lowering blood sugar levels.
Uses
-
Treatment of Type 2 Diabetes Mellitus to improve blood sugar control
How it works
Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors), Vildagliptin (dipeptidyl peptidase-4 inhibitor). Dapagliflozin increases the excretion of glucose via the kidneys, reducing blood sugar levels. Vildagliptin improves insulin secretion and decreases glucagon release in response to meals, helping to regulate blood sugar throughout the day.
Benefits
This combination therapy targets blood sugar control through two complementary mechanisms:
-
Dapagliflozin removes excess glucose through urine.
-
Vildagliptin enhances the body's natural insulin response to glucose.
Together, they help reduce both fasting and post-meal blood sugar levels.
How to use
Take the tablet exactly as prescribed by your doctor. Swallow it whole with a glass of water. Do not chew, crush, or break the tablet. Do not exceed the recommended dose.
Side Effects
Possible side effects include:
-
Headache
-
Nausea
-
Stomach upset or abdominal pain
-
Vomiting
-
Allergic reactions (such as rash or itching)
-
Increased urination
-
Symptoms of low blood sugar (hypoglycemia), especially if used with other antidiabetic medicines
If side effects persist or worsen, contact your healthcare provider.
Safety Advice
-
Inform your doctor if you have a history of kidney problems, liver disease, or urinary tract infections before starting this medication.
-
Use caution if you are pregnant, planning to become pregnant, or breastfeeding.
-
This medication is not recommended for use in children under 18 years of age, as safety and effectiveness have not been established.
-
Discuss all other medications, supplements, and herbal products you are taking with your doctor to avoid potential interactions.
Storage Conditions
Store at a temperature below 86°F (30 °C). Protect from light and moisture.
FAQs
What is the use of Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP?
Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP is an antidiabetic medicine used for the treatment of Type II Diabetes.
How does Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP work?
Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP is a combination medicine containing Vildagliptin that enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations. Dapagliflozin promotes the removal of excess sugar through urine.
If I am taking regular Insulin, do I need to talk to a Doctor?
Please consult your doctor if you have concerns and for more information on this.
What to do if I forget to take my regular prescribed dose?
If you forget to take Dapagliflozin 5 mg & Vildagliptin 50 mg S.R. Tablet IP, take it as soon as you remember. However, if it's time for the next dose, skip it and continue with your next scheduled one—don't take extra to compensate. Taking an overdose can cause your blood sugar to drop too quickly.
Manufacturer Name: Mascot Health Series Private Limited
Marketed by: First Remedy Pharmacies Private Limited
The information provided on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a physician or qualified healthcare provider for any medical concerns. Never disregard professional advice or delay seeking it based on the information you read here.

